Because of their connection to COVID-19 disease severity, we chose to perform these analyses in primary naive B cells, naïve CD4+ T cells, follicular helper T cells [26], and germinal center B cells from human tonsil, and circulating monocytes (Additional file 1 Fig S1A, Table S1). This evidence concerns the gene CD4 and COVID-19.